Anuh Pharma Stock Screener | Share Price & Fundamental Analysis
ANUHPHR
Pharmaceuticals
Screen Anuh Pharma share price with our stock screener - analyze fundamentals and track trades in your journal
Share Price NSE
₹79.24
▼
-0.23 (-0.29%)
Share Price BSE
₹79.27
▲
0.02 (0.03%)
Market Cap
₹802.09 Cr.
P/E Ratio (TTM)
15.00
P/B Ratio
2.48
EPS (TTM)
₹9.45
Dividend Yield
0.93%
Debt to Equity
0.02
52W High
₹110.40
52W Low
₹74.60
Operating Margin
8.00%
Profit Margin
5.29%
Revenue (TTM)
₹737.00
EBITDA
₹62.00
Net Income
₹39.00
Total Assets
₹507.00
Total Equity
₹326.00
Anuh Pharma Share Price History - Stock Screener Chart
Screen ANUHPHR historical share price movements with interactive charts. Analyze price trends and patterns.
Anuh Pharma Company Profile - Fundamental Screener
Screen Anuh Pharma company fundamentals and business profile. Use our stock screener to analyze sector, industry, and key company metrics for ANUHPHR shares.
Sector
Healthcare
Industry
Pharmaceuticals
Sub-Sector
Pharmaceuticals
Segment
E
ISIN
INE489G01022
Anuh Pharma Balance Sheet Screener - Fundamental Analysis
Fair Value AnalysisScreen ANUHPHR balance sheet fundamentals including assets, liabilities, and equity. Use our screener tool to analyze financial health and share price valuation metrics.
| Item | 2025 | 2024 | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 |
|---|---|---|---|---|---|---|---|---|---|---|
| Assets | ||||||||||
| Total Assets | 507 | 446 | 405 | 347 | 333 | 326 | 240 | 209 | 189 | 193 |
| Current Assets | 376 | 339 | 308 | 259 | 238 | 223 | 152 | 154 | 138 | 151 |
| Fixed Assets | 58 | 49 | 53 | 61 | 71 | 84 | 21 | 17 | 17 | 18 |
| Liabilities | ||||||||||
| Total Liabilities | 507 | 446 | 405 | 347 | 333 | 326 | 240 | 209 | 189 | 193 |
| Current Liabilities | 2 | 2 | 2 | 3 | 3 | 2 | 1 | 1 | 1 | 1 |
| Non-Current Liabilities | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Shareholders' Equity | ||||||||||
| Total Equity | 326 | 291 | 241 | 214 | 191 | 162 | 165 | 150 | 141 | 119 |
| Share Capital | 25 | 25 | 25 | 25 | 25 | 13 | 13 | 13 | 13 | 13 |
| Reserves & Surplus | 301 | 266 | 216 | 189 | 166 | 150 | 152 | 137 | 128 | 107 |
Screen ANUHPHR income statement and profit fundamentals. Analyze revenue growth, EBITDA, net profit margins, and EPS using our fundamental screener for share price evaluation.
| Item | None-None | 2025-March | 2024-March | 2023-March | 2022-March | 2021-March | 2020-March | 2019-March | 2018-March | 2017-March | 2016-March | 2015-March |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Revenue | 737 | 671 | 659 | 534 | 492 | 443 | 311 | 325 | 246 | 214 | 330 | 289 |
| Expenses | 674 | 601 | 572 | 476 | 440 | 387 | 284 | 291 | 220 | 184 | 290 | 254 |
| EBITDA | 62 | 70 | 87 | 57 | 52 | 55 | 27 | 34 | 25 | 30 | 40 | 35 |
| Operating Profit % | 8.00% | 9.00% | 12.00% | 10.00% | 10.00% | 10.00% | 7.00% | 9.00% | 8.00% | 11.00% | 11.00% | 11.00% |
| Depreciation | 10 | 9 | 9 | 10 | 12 | 15 | 7 | 2 | 2 | 2 | 2 | 3 |
| Interest | 1 | 1 | 0 | 0 | 1 | 2 | 1 | 0 | 0 | 0 | 0 | 0 |
| Profit Before Tax | 51 | 61 | 78 | 48 | 39 | 39 | 19 | 32 | 23 | 28 | 38 | 32 |
| Tax | 14 | 14 | 18 | 11 | 9 | 10 | 5 | 9 | 7 | 8 | 12 | 10 |
| Net Profit | 39 | 47 | 60 | 36 | 31 | 28 | 14 | 23 | 17 | 20 | 26 | 22 |
| EPS | 7.00 | 9.45 | 11.98 | 7.22 | 6.10 | 5.67 | 2.85 | 9.33 | 6.59 | 8.00 | 10.30 | 8.78 |
Anuh Pharma Cash Flow Screener - Liquidity Fundamentals
Screen ANUHPHR cash flow statements and liquidity fundamentals. Analyze operating, investing, and financing activities using our stock screener for share price strength assessment.
| Item | 2025-March | 2024-March | 2023-March | 2022-March | 2021-March | 2020-March | 2019-March | 2018-March | 2017-March | 2016-March |
|---|---|---|---|---|---|---|---|---|---|---|
| Operating Activities | 37 | 13 | 54 | 29 | -19 | 49 | 7 | 2 | 26 | 17 |
| Investing Activities | -20 | 1 | -44 | -8 | 52 | -77 | 3 | 2 | -20 | -5 |
| Financing Activities | -5 | -9 | -12 | -20 | -33 | 22 | -7 | -5 | -4 | -9 |
| Net Cash Flow | 12 | 5 | -2 | 2 | 0 | -5 | 4 | -1 | 2 | 2 |
Screen ANUHPHR shareholding pattern and ownership fundamentals. Analyze promoter holding, institutional investors, and share distribution using our screener for informed investment decisions.
| Item | 2025-Sept | 2025-Jul | 2025-Jun | 2025-Mar | 2024-Dec | 2024-Sept | 2024-Jun | 2024-Mar |
|---|---|---|---|---|---|---|---|---|
| Promoter Holding | 71.82% | 69.92% | 69.92% | 69.92% | 69.92% | 69.92% | 69.92% | 69.92% |
| FII Holding | 0.00% | 0.03% | 0.04% | 0.04% | 0.02% | 0.02% | 0.03% | 0.03% |
| DII Holding | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.11% |
| Govt Holding | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% |
| Public Holding | 23.86% | 25.83% | 25.89% | 25.92% | 26.02% | 26.27% | 26.30% | 26.20% |
| Other Holding | 4.33% | 4.23% | 4.16% | 4.13% | 4.04% | 3.79% | 3.75% | 3.75% |
| Shareholder Count | 28,250 | 26,157 | 24,257 | 24,235 | 24,048 | 23,910 | 23,494 | 22,237 |
Anuh Pharma Dividend Screener - Share Yield Analysis
Screen ANUHPHR dividend history and yield fundamentals. Analyze dividend payout, frequency, and returns using our stock screener for income-focused share price evaluation.
| Period | Dividend Per Share | Dividend Yield |
|---|---|---|
| 2025-March | ₹1.50 | 1.84% |
| 2024-March | ₹2.50 | 3.35% |
| 2023-March | ₹0.00 | 0.00% |
| 2022-March | ₹0.00 | 0.00% |
| 2021-March | ₹0.00 | 0.00% |
| 2020-March | ₹0.00 | 0.00% |
| 2019-March | ₹0.00 | 0.00% |
| 2018-March | ₹0.00 | 0.00% |
| 2017-March | ₹0.00 | 0.00% |
| 2016-March | ₹0.00 | 0.00% |
Anuh Pharma Index Membership - Market Screener Classification
Screen ANUHPHR by index membership and market classification. Filter stocks by major indices like NIFTY, SENSEX using our screener for systematic share price tracking.
Anuh Pharma Market Events Screener - Corporate Actions
Screen ANUHPHR market events and corporate actions affecting share price. Track splits, bonuses, buybacks, and major announcements using our stock screener for fundamental event analysis.
| Announcement Date | Record Date | Event Type | Information | Price Impact |
|---|---|---|---|---|
| Bonus | 1:1 | 13.69% | ||
| 2025-11-07 | 2025-11-07 | Quarterly Result Announcement | NA | -3.79% |
| 2025-08-22 | 2025-08-22 | Annual General Meeting | NA | -13.23% |
| 2025-08-14 | 2025-08-15 | Dividend | ₹ 1.50 /share | -16.76% |
| 2025-08-08 | 2025-08-08 | Quarterly Result Announcement | NA | -7.61% |
| 2025-07-15 | 2025-07-15 | Bonus | 1:1 | -5.91% |
| 2025-05-23 | 2025-05-23 | Quarterly Result Announcement | NA | 17.41% |
| 2025-02-07 | 2025-02-07 | Quarterly Result Announcement | NA | 5.24% |
| 2024-11-08 | 2024-11-08 | Quarterly Result Announcement | NA | 5.11% |
| 2024-08-23 | 2024-08-23 | Annual General Meeting | NA | -12.70% |
| 2024-08-16 | 2024-08-16 | Dividend | ₹ 2.50 /share | -13.94% |
| 2023-08-11 | 2023-08-11 | Dividend | ₹ 2.00 /share | 40.69% |
| 2022-08-03 | 2022-08-05 | Dividend | ₹ 1.75 /share | 9.43% |
| 2021-08-17 | 2021-08-19 | Dividend | ₹ 1.50 /share | -19.74% |
Anuh Pharma Competitors Screener - Peer Comparison
Screen ANUHPHR competitors and compare share prices across peer stocks. Use our screener to analyze sector peers, fundamentals, and relative performance for better stock selection.
| Company | Market Cap | P/E Ratio | Revenue | YoY Growth | Net Profit | RSI |
|---|---|---|---|---|---|---|
| Sun Pharmaceutical | 412,734 | 39.30 | 54,729 | 9.71% | 10,980 | 39.06 |
| Divis Laboratories | 168,851 | 68.25 | 9,712 | 18.67% | 2,191 | 44.96 |
| Torrent Pharmaceuticals | 129,357 | 59.98 | 11,539 | 6.99% | 1,911 | 59.35 |
| Cipla | 120,557 | 22.21 | 28,410 | 7.12% | 5,291 | 42.76 |
| Dr Reddys Laboratories | 105,645 | 18.46 | 33,741 | 16.73% | 5,725 | 49.97 |
| Lupin | 95,023 | 21.85 | 22,910 | 13.74% | 3,306 | 50.10 |
| Zydus Life Science | 90,707 | 18.09 | 23,511 | 18.55% | 4,615 | 34.06 |
| Mankind Pharma | 88,846 | 50.78 | 12,744 | 20.90% | 2,007 | 40.67 |
| Aurobindo Pharma | 68,901 | 20.36 | 32,346 | 9.43% | 3,484 | 46.33 |
| Alkem Laboratories | 65,390 | 27.28 | 13,458 | 3.70% | 2,216 | 37.45 |
Anuh Pharma Company Announcements - News Screener
Screen ANUHPHR latest company announcements and news updates. Filter stock news, results, and material events using our screener for share price impact analysis.
| Date | Update | Actions |
|---|---|---|
| 2025-12-05 | Announcement Under Regulation 30 (LODR) - Updates | View |
| 2025-11-17 | Announcement under Regulation 30 (LODR)-Investor Presentation | View |
| 2025-11-09 | Announcement under Regulation 30 (LODR)-Newspaper Publication | View |
| 2025-11-07 | Announcement Under Regulation 30 (LODR) - Adoption Of Revised Polices And Codes | View |
| 2025-11-07 | Results-Financial Results For September 30 2025 | View |
| 2025-11-07 | Board Meeting Outcome for Board Meeting Outcome For The Board Meeting Held On 07/11/2025 | View |
| 2025-10-31 | Board Meeting Intimation for Consideration And Approval Of Unaudited Financial Results For The Quarter And Half Year Ended 30Th September 2025. | View |
| 2025-10-10 | Compliances-Certificate under Reg. 74 (5) of SEBI (DP) Regulations 2018 | View |
| 2025-09-26 | Closure of Trading Window | View |
| 2025-09-26 | Announcement under Regulation 30 (LODR)-Newspaper Publication | View |
| 2025-09-16 | Announcement under Regulation 30 (LODR)-Credit Rating | View |
| 2025-09-11 | Announcement under Regulation 30 (LODR)-Newspaper Publication | View |
| 2025-09-09 | Announcement under Regulation 30 (LODR)-Newspaper Publication | View |
| 2025-08-26 | Announcement under Regulation 30 (LODR)-Change in Management | View |
| 2025-08-26 | Announcement Under Regulation 30 - General Updates | View |
| 2025-08-26 | Shareholder Meeting / Postal Ballot-Scrutinizers Report | View |
| 2025-08-22 | Shareholder Meeting / Postal Ballot-Outcome of AGM | View |
| 2025-08-22 | Announcement under Regulation 30 (LODR)-Investor Presentation | View |
| 2025-08-20 | Intimation Regarding 100 Days Campaign - Saksham Niveshak | View |
| 2025-08-09 | Announcement under Regulation 30 (LODR)-Newspaper Publication | View |